miR-424/322 attenuates cardiac remodeling by modulating the nuclear factor-activated T-cell 3/furin pathway

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Epigenetics

Background:

• Cardiac remodeling, including fibrosis and hypertrophy, is a significant factor in heart failure and arrhythmias.
• Nuclear factor-activated T-cell cytoplasmic (NFATc) is a critical regulator of cardiac remodeling.
• MicroRNA (miR)-424/322's role in cardiovascular pathophysiology, particularly in cardiac remodeling, is under investigation.

Purpose of the Study:

• To investigate the role of miR-424/322 in cardiac remodeling.
• To identify molecular targets of miR-424/322 involved in cardiac hypertrophy and fibrosis.
• To explore the therapeutic potential of miR-424/322 in cardiac remodeling.

Main Methods:

• In vitro studies using human cardiac fibroblasts and H9c2 cells.
• In vivo studies utilizing a murine model of angiotensin II-induced cardiac remodeling.
• Molecular techniques including immunoblotting, real-time PCR, and dual-luciferase reporter assays.

Main Results:

• miR-322 knockout mice exhibited increased susceptibility to angiotensin II-induced cardiac fibrosis and hypertrophy.
• miR-424/322 mimics reversed angiotensin II-induced fibrosis, hypertrophy, and proliferation by targeting NFATc3 and furin.
• The NFATc3/miR-424/322/furin axis was identified as crucial in cardiac remodeling.

Conclusions:

• The NFATc3/miR-424/322/furin axis is essential for cardiac remodeling.
• Exogenous miR-322 mimics demonstrate potential therapeutic applications for cardiac remodeling.